Wednesday, July 17, 2013 8:13:14 PM
Jul 17 6.58% 0.17 0.15 0.16 -5.88% 64,942 987,168
Jul 16 7.51% 0.17 0.16 0.17 0.00% 56,855 757,496
Jul 15 27.15% 0.19 0.12 0.17 -10.53% 713,482 2,628,094
Jul 12 48.69% 0.21 0.19 0.19 0.00% 699,601 1,436,950
Jul 11 53.30% 0.21 0.19 0.19 0.00% 1,129,492 2,119,303
Jul 10 72.41% 0.20 0.19 0.19 0.00% 596,768 824,141
Jul 09 33.49% 0.20 0.19 0.19 -5.00% 217,874 650,627
Jul 08 48.82% 0.20 0.19 0.20 +5.26% 429,597 879,938
Jul 05 60.07% 0.20 0.19 0.19 0.00% 283,593 472,137
Jul 04 0% 0.19 0.19 0.19 0.00% 0 0
Jul 03 62.11% 0.19 0.19 0.19 0.00% 87,256 140,480
Jul 02 53.20% 0.20 0.19 0.19 -5.00% 110,769 208,216
Jul 01 57.29% 0.20 0.19 0.20 +5.26% 397,123 693,159
Jun 28 55.68% 0.20 0.19 0.19 -5.00% 119,175 214,019
Jun 27 60.48% 0.20 0.19 0.20 +5.26% 308,391 509,941
Jun 26 61.70% 0.20 0.19 0.19 0.00% 209,659 339,815
Jun 25 51.36% 0.20 0.19 0.19 0.00% 127,537 248,331
Jun 24 43.58% 0.20 0.19 0.19 -5.00% 153,964 353,293
Jun 21 40.97% 0.20 0.19 0.20 0.00% 274,981 671,123
Jun 20 27.76% 0.20 0.19 0.20 0.00% 143,316 516,239
Jun 19 55.42% 0.20 0.20 0.20 0.00% 552,032 996,028
Jun 18 57.89% 0.20 0.19 0.20 0.00% 93,250 161,085
Jun 17 57.39% 0.20 0.19 0.20 NA 102,437 178,492
Do you see it? short interest after that huge drop on Monday dropped from being 60% short daily volume each day down to 7% short volume each day! The evidence is clear folks the shorts covered!
Recent PHIO News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 09:00:13 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/20/2024 09:03:23 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 05/20/2024 08:59:26 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/17/2024 08:45:23 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/17/2024 01:04:34 PM
- Phio Pharmaceuticals Secures New Investor • GlobeNewswire Inc. • 05/17/2024 01:00:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 01:00:13 PM
- Phio Pharmaceuticals Presents This Week at the Society for Investigative Dermatology (SID) • GlobeNewswire Inc. • 05/16/2024 12:00:00 PM
- Phio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation Study • GlobeNewswire Inc. • 05/15/2024 05:00:00 PM
- Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update • GlobeNewswire Inc. • 05/09/2024 09:25:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 09:23:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 09:20:56 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/08/2024 09:04:03 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/08/2024 09:02:05 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 05/08/2024 09:00:34 PM
- Phio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO) • GlobeNewswire Inc. • 04/30/2024 11:30:00 AM
- Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells • GlobeNewswire Inc. • 04/22/2024 05:10:09 PM
- Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID) • GlobeNewswire Inc. • 04/16/2024 11:30:00 AM
- Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT) • GlobeNewswire Inc. • 04/11/2024 11:30:00 AM
- National Spotlight Features Phio’s Innovative RNAi Technology Platform • GlobeNewswire Inc. • 04/03/2024 11:30:00 AM
- Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update • GlobeNewswire Inc. • 04/02/2024 11:30:00 AM
- Phio Pharmaceuticals Presenting Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies • GlobeNewswire Inc. • 03/21/2024 11:30:00 AM
- Phio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, The George Washington University, and Integrity Research • GlobeNewswire Inc. • 03/13/2024 06:00:25 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM